Wei-wen S. Su

Keelung Branch
Keelung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 103 publications

HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.

HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.

Journal: Hepatology international

Published: June 09, 2026

Cost-Effectiveness of Fecal Immunochemical Testing Alone vs Co-Testing With Helicobacter pylori Stool Antigen.

Cost-Effectiveness of Fecal Immunochemical Testing Alone vs Co-Testing With Helicobacter pylori Stool Antigen.

Journal: JAMA

Published: June 01, 2026

Towards hepatitis C elimination with integrated risk-based screening and decentralized care in Taiwan.

Towards hepatitis C elimination with integrated risk-based screening and decentralized care in Taiwan.

Journal: Nature communications

Published: August 19, 2025

Micro-elimination of hepatitis C in patients with chronic kidney disease and diabetes in Taiwan.

Micro-elimination of hepatitis C in patients with chronic kidney disease and diabetes in Taiwan.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: July 22, 2025

Changhua Integrated Program to Stop HCV Infection (CHIPS-C): A county-wide model for integrated HCV elimination in Taiwan.

Changhua Integrated Program to Stop HCV Infection (CHIPS-C): A county-wide model for integrated HCV elimination in Taiwan.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: July 05, 2025

Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B.

Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B.

Journal: JHEP reports : innovation in hepatology

Published: June 20, 2025

Effectiveness and Safety of Switching to Fixed-Dose, Preservative-Free Tafluprost/Timolol in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: A Real-World Study in Taiwan.

Effectiveness and Safety of Switching to Fixed-Dose, Preservative-Free Tafluprost/Timolol in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: A Real-World Study in Taiwan.

Journal: Cureus

Published: June 12, 2025

High-Accuracy Digitization of Humphrey Visual Field Reports Using Convolutional Neural Networks.

High-Accuracy Digitization of Humphrey Visual Field Reports Using Convolutional Neural Networks.

Journal: Translational vision science & technology

Published: May 05, 2025

Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan.

Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan.

Journal: The Kaohsiung journal of medical sciences

Published: April 08, 2025

Switching to tenofovir alafenamide in virally-suppressed chronic hepatitis B patients with renal/hepatic impairment: Phase 2 study sub-analysis from Taiwan.

Switching to tenofovir alafenamide in virally-suppressed chronic hepatitis B patients with renal/hepatic impairment: Phase 2 study sub-analysis from Taiwan.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: March 06, 2025

Long-term risk of depression and the impact of risk factors among chronic hepatitis C patients after successful antiviral therapy: A nationwide real-world Taiwanese cohort (T-COACH).

Long-term risk of depression and the impact of risk factors among chronic hepatitis C patients after successful antiviral therapy: A nationwide real-world Taiwanese cohort (T-COACH).

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: February 21, 2025

Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.

Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.

Journal: The Kaohsiung journal of medical sciences

Published: February 13, 2025

Showing 1-12 of 103

Last Updated: 09/26/2026